133 related articles for article (PubMed ID: 16197964)
1. Identification and synthesis of novel alkaloids from the root system of Nicotiana tabacum: affinity for neuronal nicotinic acetylcholine receptors.
Wei X; Sumithran SP; Deaciuc AG; Burton HR; Bush LP; Dwoskin LP; Crooks PA
Life Sci; 2005 Dec; 78(5):495-505. PubMed ID: 16197964
[TBL] [Abstract][Full Text] [Related]
2. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
[TBL] [Abstract][Full Text] [Related]
3. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
[TBL] [Abstract][Full Text] [Related]
4. Prenylated indole alkaloids from Flustra foliacea with subtype specific binding on NAChRs.
Peters L; Wright AD; Kehraus S; Gündisch D; Tilotta MC; König GM
Planta Med; 2004 Oct; 70(10):883-6. PubMed ID: 15490312
[TBL] [Abstract][Full Text] [Related]
5. An electrophysiological characterization of naturally occurring tobacco alkaloids and their action on human α4β2 and α7 nicotinic acetylcholine receptors.
Alijevic O; McHugh D; Rufener L; Mazurov A; Hoeng J; Peitsch M
Phytochemistry; 2020 Feb; 170():112187. PubMed ID: 31865001
[TBL] [Abstract][Full Text] [Related]
6. Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
Crooks PA; Ayers JT; Xu R; Sumithran SP; Grinevich VP; Wilkins LH; Deaciuc AG; Allen DD; Dwoskin LP
Bioorg Med Chem Lett; 2004 Apr; 14(8):1869-74. PubMed ID: 15050618
[TBL] [Abstract][Full Text] [Related]
7. Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.
Dwoskin LP; Sumithran SP; Zhu J; Deaciuc AG; Ayers JT; Crooks PA
Bioorg Med Chem Lett; 2004 Apr; 14(8):1863-7. PubMed ID: 15050617
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of rat alpha3* and alpha7 nicotinic acetylcholine receptors by tetrandrine and closely related bis-benzylisoquinoline derivatives.
Virginio C; Graziani F; Terstappen GC
Neurosci Lett; 2005 Jun; 381(3):299-304. PubMed ID: 15896488
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic nicotine treatment on localization of neuronal nicotinic acetylcholine receptors at cellular level.
Pakkanen JS; Stenfors J; Jokitalo E; Tuominen RK
Synapse; 2006 Jun; 59(7):383-93. PubMed ID: 16485261
[TBL] [Abstract][Full Text] [Related]
10. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
[TBL] [Abstract][Full Text] [Related]
11. Lycaconitine revisited: partial synthesis and neuronal nicotinic acetylcholine receptor affinities.
Jacyno JM; Harwood JS; Lin NH; Campbell JE; Sullivan JP; Holladay MW
J Nat Prod; 1996 Jul; 59(7):707-9. PubMed ID: 8759171
[TBL] [Abstract][Full Text] [Related]
12. (+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype.
Tasso B; Novelli F; Sparatore F; Fasoli F; Gotti C
J Nat Prod; 2013 Apr; 76(4):727-31. PubMed ID: 23461628
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
Egleton RD; Brown KC; Dasgupta P
Pharmacol Ther; 2009 Feb; 121(2):205-23. PubMed ID: 19063919
[TBL] [Abstract][Full Text] [Related]
14. Structure activity studies of ring E analogues of methyllycaconitine. Part 2: Synthesis of antagonists to the alpha3beta4* nicotinic acetylcholine receptors through modifications to the ester.
Bergmeier SC; Ismail KA; Arason KM; McKay S; Bryant DL; McKay DB
Bioorg Med Chem Lett; 2004 Jul; 14(14):3739-42. PubMed ID: 15203153
[TBL] [Abstract][Full Text] [Related]
15. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
Sidhpura N; Redfern P; Wonnacott S
Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
[TBL] [Abstract][Full Text] [Related]
18. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
[TBL] [Abstract][Full Text] [Related]
19. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
[TBL] [Abstract][Full Text] [Related]
20. Functional characterisation of genes involved in pyridine alkaloid biosynthesis in tobacco.
Häkkinen ST; Tilleman S; Swiatek A; De Sutter V; Rischer H; Vanhoutte I; Van Onckelen H; Hilson P; Inzé D; Oksman-Caldentey KM; Goossens A
Phytochemistry; 2007; 68(22-24):2773-85. PubMed ID: 18001808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
